Hanson McClain Advisors »

Mink Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $2 2 1.00
2023-12-31 $3 2 1.50
2023-09-30 $3 2 1.50
2023-06-30 $5 2 2.50